Acadia Healthcare Company Inc (NASDAQ:ACHC) currently has a daily average trading volume of 1.54M but it saw 1959808 shares traded in last market. With a market cap of 3.63B USD, the company’s current market price of $39.10 came rising about 5.42 while comparing to the previous closing price of $37.09. In past 52 weeks, the stock remained buoying in the range of price level as high as $87.77 and as low as $36.50. In the recent trading on the day, stock has struck highest price mark of $36.7905 while lowest mark touched by it was $39.89.
Taking a look at 20-day trading activity of Acadia Healthcare Company Inc (ACHC) gives us an average price of $43.21, while its current price level is -55.45% below from 52-week high level whereas it is 7.12% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $55.72 while that of 200 days or SMA-200 reads an average of $68.80. A closer look into the stock’s movement over the week reveals that its volatility is standing at 4.07% during that period while stretching the period over a month that decreases to 3.60%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 27.66 which implies that the stock is in oversold territory.
Deutsche Bank upgraded its recommendation for the stock as a “Hold” from “Sell” on April 25, 2024 while assigning a price target of $70. Barclays also issued its recommendations for the stock as it initiated the price target for the stock is $100.
Over the week, ACHC’s stock price is moving -1.83% down while it is -24.31% when we observe its performance for the past one month. Year-to-date it is -49.72% down and over the past year, the stock is showing a downside performance of -46.16%.
Currently, Acadia Healthcare Company Inc’s total number of outstanding shares is 91.26M. Company’s return on investment (ROI) stands at 5.68% and return on equity (ROE) at 9.77%. It has a price to earnings ratio (P/E ratio) of 12.82 while having a 10.71 of forward P/E ratio. Stock’s beta reads 1.30. Stock has a price to book (P/B) ratio of 1.18 while price to sale or P/S ratio amounts to 1.16. Its return on asset (ROA) is 5.01% on average.
